CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Austria
Summary
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Austria". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Austria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and inhouse analysis by GlobalData's team of industry experts.
Austria is one of the largest healthcare markets, with a strong focus on pharmaceutical RD. The value of the Austrian pharmaceutical market declined from $3.30 billion in 2010 to $3.23 billion in 2016, at a negative compound annual growth rate CAGR of 0.33%. However, in terms of Euro, the market value increased from 2.48 billion in 2010 to 2.87 billion in 2017, at a CAGR of 2%. The decline in the market value in Euro terms was driven by the fluctuations in the exchange rate of the Euro versus the US dollar and increased consumption of generics. The Austrian medical device market was valued at $1.63 billion in 2010 and increased to $1.95 billion in 2017.The main segments were nephrology and urology devices, orthopedic devices, ophthalmic devices, cardiovascular devices, and in vitro diagnostics. The robust healthcare system, high focus on RD and change in demographics are expected to drive the growth of the pharmaceutical market. However, generic substitution and shortage of specialized staff act as a major barrier for the pharmaceutical market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market Novartis, Pfizer, Merck, Sanofi and Gerot Lannach and profiles and SWOT analyses of the major players in the medical device market Medtronic, GE Healthcare, Roche, DePuy and Sanochemia Pharmazeutika
Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Austria
Porter's five forces analysis for pharmaceutical and medical devices market of Austria
An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the Austrian healthcare market.
Reasons to buy
This report will enhance your decisionmaking capability by allowing you to
Develop business strategies by understanding the trends shaping and driving the Austrian healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Identify, understand, and capitalize on the opportunities and challenges in the Austrian healthcare market.